The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation.
Allogeneic stem cell transplantation is used in the treatment of younger patients with severe hematological diseases, especially hematological malignancies, and acute graft versus host disease (GVHD) is then an important immune-mediated posttransplant complication. Several risk factors for acute GVHD have been identified, including pretransplant factors that possibly influence the posttranspant course through their effects on host immunocompetent cells. Metabolic regulation is important for immunoregulation, and we therefore investigated whether the pretransplant metabolic status of allotransplant recipients was associated with later acute GVHD. In our population-based study we investigated the systemic (serum) metabolic profile for 86 consecutive allotransplant recipients. The samples were collected before start of the pretransplant conditioning therapy. Patients who developed later acute GVHD especially showed altered pretransplant amino acid metabolism, including (1) altered metabolism of immunoregulatory branched chain amino acids (leucine, isoleucine and valine); and (2) altered levels of potentially proinflammatory tyrosine metabolites (p-cresol sulphate, 3-phenylpropionate) formed by the gastrointestinal microbial flora. However, isobutyrylcarnitine and propyonylcarnitine levels were also altered; the carnitines are important for the transport of fatty acids and may also be important for the release of immunoregulatory cytokines in allotransplant recipients. These metabolic alterations were associated with an ongoing pretransplant acute phase reaction or early hematopoietic/immune reconstitution. Thus, allotransplant recipients developing acute GVHD showed altered preconditioning/pretransplant levels of several immunoregulatory metabolites. Our hypothesis is that these metabolites alter or activate recipient immunocompetent cells and thereby enhance or initiate anti-recipient immune reactivity.
grid.7914.b0000000419367443Section Hematology, Institute of Clinical Science, University of Bergen, Bergen, Norway ; grid.412008.f0000000097531393Section Hematology, Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway.
Håkon
H
Reikvam
grid.7914.b0000000419367443Section Hematology, Institute of Clinical Science, University of Bergen, Bergen, Norway.
Kimberley
K
Hatfield
grid.7914.b0000000419367443Section Hematology, Institute of Clinical Science, University of Bergen, Bergen, Norway ; grid.412008.f0000000097531393Section Hematology, Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway.
Øystein
Ø
Bruserud
Acute graft versus host disease; Acute leukemia; Allogeneic stem cell transplantation; Metabolomics